Zivira Labs Profile
Key Indicators
- Authorised Capital ₹ 8.00 M
as on 23-10-2024
- Paid Up Capital ₹ 8.00 M
as on 23-10-2024
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.57 Cr
as on 23-10-2024
- Satisfied Charges ₹ 1.75 Cr
as on 23-10-2024
- Revenue 38.96%
(FY 2023)
- Profit 270.22%
(FY 2023)
- Ebitda 54.46%
(FY 2023)
- Net Worth 50.80%
(FY 2023)
- Total Assets -0.69%
(FY 2023)
About Zivira Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 8.00 M.
The company currently has active open charges totaling ₹3.57 Cr. The company has closed loans amounting to ₹1.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ponnuraman Kumaran, Poosaikannu Sundarashanthi, Prashanth Rao, and One other member serve as directors at the Company.
- CIN/LLPIN
U36109MH2017PTC299902
- Company No.
299902
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Sep 2017
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Zivira Labs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ponnuraman Kumaran  | Managing Director | 19-Sep-2017 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prashanth Rao | Director | 21-Feb-2020 | Current |
| Poosaikannu Sundarashanthi | Director | 19-Sep-2017 | Current |
| Catherine Danan | Director | 21-Feb-2020 | Current |
Financial Performance of Zivira Labs.
Zivira Labs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 38.96% increase. The company also saw a substantial improvement in profitability, with a 270.22% increase in profit. The company's net worth Soared by an impressive increase of 50.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zivira Labs?
In 2023, Zivira Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 14 Mar 2022 | ₹3.57 Cr | Open |
Others Creation Date: 01 Mar 2021 | ₹1.50 M | Satisfied |
Others Creation Date: 23 Dec 2019 | ₹1.60 Cr | Satisfied |
How Many Employees Work at Zivira Labs?
Zivira Labs has a workforce of 112 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zivira Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zivira Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
